Zura Bio Limited (ZURA)
NASDAQ: ZURA · IEX Real-Time Price · USD
3.430
-0.200 (-5.51%)
At close: Jul 2, 2024, 4:00 PM
3.490
+0.060 (1.75%)
After-hours: Jul 2, 2024, 7:55 PM EDT
Zura Bio Stock Forecast
ZURA's stock price has decreased by -57.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Zura Bio stock have an average target of 19.2, with a low estimate of 10 and a high estimate of 26. The average target predicts an increase of 459.77% from the current stock price of 3.43.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for Zura Bio stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 2 |
| Buy | 1 | 1 | 2 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 12, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 → $21 | Buy | Maintains | $16 → $21 | +512.24% | May 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $26 | Buy | Initiates | $26 | +658.02% | May 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $17 → $16 | Buy | Reiterates | $17 → $16 | +366.47% | Apr 1, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.53
from -2.09
EPS Next Year
-0.82
from -0.53
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 26.3M |
| Avg | n/a | n/a | 5.1M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.39 | -0.54 | -0.82 |
| Avg | -0.53 | -0.82 | -0.97 |
| Low | -0.71 | -1.00 | -1.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.